Literature DB >> 16273645

Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease.

Wolfgang Kratzer1, Mark-M Haenle, Richard-A Mason, Christian von Tirpitz, Volker Kaechele.   

Abstract

AIM: To investigate the effect of chronic inflammatory bowel disease (CIBD) specific risk factors for cholecystolithiasis, as duration and involvement pattern of the disease and prior surgery in patients with Crohn's disease (CD) and ulcerative colitis (UC).
METHODS: A total of 222 patients with CD (135 females, 87 males; average age, 35.8+/-11.8 years; range 17-81 years) and 88 patients with UC (39 females, 49 males; average age, 37.2+/-13.6 years; range 16-81 years) underwent clinical and ultrasound examinations. Besides age, sex and degree of obesity, patients' CIBD specific parameters, including duration and extent of disease and prior operations were documented and evaluated statistically using logistic regression.
RESULTS: The overall prevalence of gallbladder stone disease in patients with CD was 13% (n = 30). Only age could be shown to be an independent risk factor (P = 0.014). Compared to a collective representative for the general population in the same geographic region, the prevalence of cholecystolithiasis was higher in all corresponding age groups. Patients with UC showed an overall prevalence of gallbladder stone disease of only 4.6%.
CONCLUSION: Disease-specific factors such as duration and extent of disease, and prior surgery are independent risk factors for the development of cholecystolithiasis in patients with CIBD.

Entities:  

Mesh:

Year:  2005        PMID: 16273645      PMCID: PMC4436635          DOI: 10.3748/wjg.v11.i39.6170

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Gallstones after ileostomy and ileal resection.

Authors:  G L Hill; W S Mair; J C Goligher
Journal:  Gut       Date:  1975-12       Impact factor: 23.059

2.  Bile composition in patients with ileal resection due to Crohn's disease.

Authors:  A Lapidus; C Einarsson
Journal:  Inflamm Bowel Dis       Date:  1998-05       Impact factor: 5.325

3.  Gallstone prevalence and biliary lipid composition in inflammatory bowel disease.

Authors:  J W Marks; D R Conley; T L Capretta; G G Bonorris; A Chung; M J Coyne; L J Schoenfield
Journal:  Am J Dig Dis       Date:  1977-12

Review 4.  Disturbances of bile acid metabolism in intestinal disease.

Authors:  K W Heaton
Journal:  Clin Gastroenterol       Date:  1977-01

5.  Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center.

Authors:  Stefano Bargiggia; Giovanni Maconi; Marco Elli; Paola Molteni; Sandro Ardizzone; Fabrizio Parente; Ivan Todaro; Salvatore Greco; Guendalina Manzionna; Gabriele Bianchi Porro
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

6.  The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease.

Authors:  A Lapidus; M Bångstad; M Aström; O Muhrbeck
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

7.  Effects of colectomy on bile composition, cholesterol saturation and cholesterol crystal formation in humans.

Authors:  J E Akerlund; C Einarsson
Journal:  Int J Colorectal Dis       Date:  2000-08       Impact factor: 2.571

8.  Cholelithiasis in ileostomy patients.

Authors:  A Kurchin; J E Ray; E I Bluth; C R Merritt; J B Gathright; B F Pehrsson; B T Ferrari
Journal:  Dis Colon Rectum       Date:  1984-09       Impact factor: 4.585

9.  Pathogenesis of gall stones in Crohn's disease: an alternative explanation.

Authors:  R Hutchinson; P N Tyrrell; D Kumar; J A Dunn; J K Li; R N Allan
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  Ultrasound evaluation of small bowel abnormalities.

Authors:  E I Bluth
Journal:  Am J Gastroenterol       Date:  1983-12       Impact factor: 10.864

View more
  8 in total

1.  Incidence and risk of intestinal and extra-intestinal complications in Medicaid patients with inflammatory bowel disease: a 5-year population-based study.

Authors:  Gaurav Arora; Gurkirpal Singh; Shweta Vadhavkar; Shamita B Shah; Ajitha Mannalithara; Alka Mithal; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2010-04-29       Impact factor: 3.199

2.  Hepatopancreatobiliary manifestations of inflammatory bowel disease.

Authors:  Kazuhiko Nakamura; Tetsuhide Ito; Kazuhiro Kotoh; Eikichi Ihara; Haruei Ogino; Tsutomu Iwasa; Yoshimasa Tanaka; Yoichiro Iboshi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2012-01-06

Review 3.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

4.  Spontaneous gallbladder pathology in baboons.

Authors:  J L Slingluff; J T Williams; L Blau; A Blau; E J Dick; G B Hubbard
Journal:  J Med Primatol       Date:  2009-09-28       Impact factor: 0.667

5.  Increased risk of asymptomatic gallstones in patients with ulcerative colitis.

Authors:  Jung Hoon Ha; Young Sook Park; Choon Sik Seon; Byung Kwan Son; Sang Bong Ahn; Young Kwan Jo; Seong Hwan Kim; Yun Ju Jo; Jung Hwan Kim; Jee Hye Han; Yoon Young Jung; Sook Hee Chung
Journal:  Intest Res       Date:  2015-04-27

6.  Association between Inflammatory Bowel Disease and Cholelithiasis: A Nationwide Population-Based Cohort Study.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Chia-Hung Kao
Journal:  Int J Environ Res Public Health       Date:  2018-03-14       Impact factor: 3.390

7.  Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.

Authors:  Stefania Fagagnini; Henriette Heinrich; Jean-Benoît Rossel; Luc Biedermann; Pascal Frei; Jonas Zeitz; Marianne Spalinger; Edouard Battegay; Lukas Zimmerli; Stephan R Vavricka; Gerhard Rogler; Michael Scharl; Benjamin Misselwitz
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

Review 8.  Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.

Authors:  Stefano Mazza; Sara Soro; Maria Chiara Verga; Biagio Elvo; Francesca Ferretti; Fabrizio Cereatti; Andrea Drago; Roberto Grassia
Journal:  World J Hepatol       Date:  2021-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.